Efficacy of Midodrine for Neurogenic Orthostatic Hypotension-Reply

JAMA: The Journal of the American Medical Association

Volumn 278, Issue 5, 1997, Pages 388-

  Low, Phillip A ^a   Clinic, Mayo ^a   Gilden, Janice L ^b   Freeman, Roy ^c   ke Ning, Sheng ^d   Mcelligott, Mary Ann ^d  

^a The Chicago Medical School ^*  (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d Roberts Pharmaceutical Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; MIDODRINE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;

HUMAN; HYPOTENSION, ORTHOSTATIC; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFICACY; HYPERTENSION; LETTER; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; SUPINE POSITION;

ADRENERGIC ALPHA-AGONISTS; HUMANS; HYPOTENSION, ORTHOSTATIC; MIDODRINE;

EID: 17044453335     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03550050050029     Document Type: Letter

References (2)

1. Wright A, Opfer-Gehrking TL,McElligott MA, Low PA. Double-blind randomized dose-response study of midodrine in patients with neurogenic orthostatic hypotension. Neurology. 1995;4:A396.
2. Gilden JL, Kaufmann H. Midodrine therapy in neurogenic orthostatic hypotension: a double-blind placebo-controlled study. Clin Auton Res. 1994;4:203A.